Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 1194-1203, April 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dahl, G. A.
Right arrow Articles by Miller, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dahl, G. A.
Right arrow Articles by Miller, J. A.

Comparative Carcinogenicities and Mutagenicities of Vinyl Carbamate, Ethyl Carbamate, and Ethyl N-Hydroxycarbamate1

Gary A. Dahl2, Elizabeth C. Miller3 and James A. Miller

McArdle Laboratory for Cancer Research, University of Wisconsin Center for Health Sciences, Madison, Wisconsin 53706

When administered during the first 5 weeks after birth, vinyl and ethyl carbamates each induced ear duct and hepatic carcinomas and neurofibrosarcomas of the ear lobe in Fischer rats. Vinyl carbamate was more active than ethyl carbamate for the induction of the latter two types of tumors. Similarly, vinyl carbamate administered in the first 3.5 weeks after birth induced more liver tumors, thymomas, lung adenomas, and Harderian gland tumors in C57BL/6J x C3H/HeJ F1 mice than did ethyl carbamate. These data extend our earlier data on the much greater potency of vinyl carbamate than of ethyl carbamate for the induction of lung adenomas in A/J and CD-1 mice and for the initiation of skin tumors in CD-1 mice. CD3CD2-O-CO-NH2 did not differ significantly from CH3CH2-O-CO-NH2 for the induction of lung tumors in A/J mice; tert-butyl carbamate had no significant activity in the latter mouse strain.

High doses of the mixed-function oxidase inhibitor 2-(2,4-dichloro-6-phenyl)phenoxyethylamine inhibited the induction of lung adenomas in A/J mice by ethyl N-hydroxycarbamate; lung tumor induction by ethyl or vinyl carbamate was not inhibited. A lower dose of the above inhibitor or of 2-diethylaminoethyl-2,2-diphenylvalerate did not significantly inhibit lung adenoma induction by any of these carbamates. In confirmation of previous reports by other investigators, administration of caffeine concurrently with ethyl carbamate inhibited the formation of lung adenomas in A/J mice; no consistent inhibition was obtained under the same conditions when vinyl carbamate or ethyl N-hydroxycarbamate was the carcinogen.

Since reduced nicotinamide adenine dinucleotide phosphate-fortified duck liver microsome-cytosol preparations can dehydrogenate aflatoxin B2 (2,3-CH2-CH2-) to aflatoxin B1 (2,3-CH=CH-), the ability of this system to convert ethyl carbamate to vinyl carbamate was examined. Vinyl carbamate was not detected as a metabolite. Furthermore, ethyl carbamate was not mutagenic for Salmonella typhimurium TA 100 in the presence of a rat and duck liver system that metabolized both vinyl carbamate and aflatoxin B2 to mutagens. Ethyl N-hydroxycarbamate showed very weak direct mutagenic activity (2 to 3 revertants/µmol) for S. typhimurium strains TA 98, TA 1535, and TA 100; both duck and rat liver preparations fortified with reduced nicotinamide adenine dinucleotide phosphate and reduced nicotinamide adenine dinucleotide reduced the mutagenic activity.

An improved synthesis of vinyl carbamate, similar to that developed independently by Olofson et al. for some N-substituted enol carbamates, is presented.

1 This work was supported by Grants CA-07175, CA-22484, and CA-09135 from the National Cancer Institute, USPHS.

2 Present address: Centre National de Recherches Agronomiques, Route de Saint-Cyr, 78000 Versailles, France.

3 To whom requests for reprints should be addressed.

Received 10/22/79. Accepted 1/ 7/80.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
L. G. Hernandez and P.-G. Forkert
Inhibition of vinyl carbamate-induced mutagenicity and clastogenicity by the garlic constituent diallyl sulfone in F1 (Big Blue(R) x A/J) transgenic mice
Carcinogenesis, August 1, 2007; 28(8): 1824 - 1830.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P.-G. Forkert, M. Kaufmann, G. Black, R. Bowers, H. Chen, K. Collins, A. Sharma, and G. Jones
Oxidation of Vinyl Carbamate and Formation of 1,N6-Ethenodeoxyadenosine in Murine Lung
Drug Metab. Dispos., May 1, 2007; 35(5): 713 - 720.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. I. Ghanayem
Inhibition of Urethane-Induced Carcinogenicity in Cyp2e1-/- in Comparison to Cyp2e1+/+ Mice
Toxicol. Sci., February 1, 2007; 95(2): 331 - 339.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
U. Hoffler and B. I. Ghanayem
INCREASED BIOACCUMULATION OF URETHANE IN CYP2E1-/- VERSUS CYP2E1+/+ MICE
Drug Metab. Dispos., August 1, 2005; 33(8): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. Takahashi, G. E. Dinse, J. F. Foley, J. F. Hardisty, and R. R. Maronpot
Comparative Prevalence, Multiplicity, and Progression of Spontaneous and Vinyl Carbamate-Induced Liver Lesions in Five Strains of Male Mice
Toxicol Pathol, August 1, 2002; 30(5): 599 - 605.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
K. Toyosawa, K. Okimoto, I. Kobayashi, K. Kijima, E. Kikawa, M. Kohchi, T. Koujitani, K. Tanaka, and N. Matsuoka
Di(2-ethylhexyl)phthalate Induces Hepatocellular Adenoma in Transgenic Mice Carrying a Human Prototype c-Ha-ras Gene in a 26-Week Carcinogenicity Study
Toxicol Pathol, June 1, 2001; 29(4): 458 - 466.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
P.-G. Forkert, R. P. Lee, and K. Reid
Involvement of CYP2E1 and Carboxylesterase Enzymes in Vinyl Carbamate Metabolism in Human Lung Microsomes
Drug Metab. Dispos., March 1, 2001; 29(3): 258 - 263.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
A. P. Titis and P.-G. Forkert
Strain-Related Differences in Bioactivation of Vinyl Carbamate and Formation of DNA Adducts in Lungs of A/J, CD-1, and C57BL/6 Mice
Toxicol. Sci., January 1, 2001; 59(1): 82 - 91.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. P. Lee and P.-G. Forkert
Inactivation of Cytochrome P-450 (CYP2E1) and Carboxylesterase (Hydrolase A) Enzymes by Vinyl Carbamate in Murine Pulmonary Microsomes
Drug Metab. Dispos., February 1, 1999; 27(2): 233 - 239.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
K. Mitsumori, H. Koizumi, T. Nomura, and S. Yamamoto
Pathological Features of Spontaneous and Induced Tumors in Transgenic Mice Carrying a Human Prototype c-Ha-ras Gene Used for Six-Month Carcinogenicity Studies
Toxicol Pathol, July 1, 1998; 26(4): 520 - 531.
[Abstract] [PDF]


Home page
International Journal of ToxicologyHome page
R. W. Benson and F. A. Beland
Modulation of Urethane (Ethyl Carbamate) Carcinogenicity by Ethyl Alcohol: A Review
International Journal of Toxicology, November 1, 1997; 16(6): 521 - 544.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.